The importanceof recognizing this phenotype lies in the global burden of hypertension and theopportunity to identify mechanisms that allow targeted therapy with widely availablemineralocorticoid receptor antagonists, and that may also be a potential target foremerging treatments such as aldosterone synthase inhibitors (69). This evidence concerns the gene CYP11B2 and hypertensive disorder.